MétaCan
Menu
Back to cohort

Thymidylate synthase and thymidine phosphorylase expression in resected colorectal liver metastases do not predict overall survival nor response to chemotherapy

2004· article· en· W2244983407 on OpenAlexaff
Maurice Blitz, Linda Carroll, Charles Butts, Terence Moyana, N. M. Kneteman, Lawrence D. Jewell, H.C. Birnboim, Derek J. Jonker, Jean A. Maroun, D. Bigam

Bibliographic record

VenueJournal of Clinical Oncology · 2004
Typearticle
Languageen
FieldMedicine
TopicColorectal Cancer Treatments and Studies
Canadian institutionsOttawa Regional Cancer FoundationUniversity of Alberta
Fundersnot available
KeywordsThymidylate synthaseThymidine phosphorylaseMedicineInternal medicineChemotherapyColorectal cancerImmunohistochemistryDihydropyrimidine dehydrogenaseAdjuvantGastroenterologyOncologyFluorouracilCancer

Abstract

fetched live from OpenAlex

3605 Background: Enzyme expression has been reported to be of both predictive and prognostic significance in patients with colorectal liver metastases (CLM). We determined whether thymidylate synthase (TS) and/or thymidine phosphorylase (TP) can be used to determine the prognosis of patients with CLM who have undergone potentially curative hepatic resection and whether TS and/or TP status can be used to predict which patients would be likely to benefit from (neo)adjuvant chemotherapy. Methods: Paraffin tumor blocks from 99 patients who received potentially curative liver resections for CLM were evaluated. TS and TP expression were assessed by immunohistochemistry (IHC) assays. Overall survival (OS) and disease-free survival (DFS) were compared between high and low expressors of TS and TP singly and in combination. The predictive value for response to (neo)adjuvant chemotherapy of TS alone as well as the TS / TP combination were evaluated. Results: Median OS for the TS+ group (n=47) was 4.51 years and DFS was 2.37 years, which were not significantly different from those of the TS- group (n=52): 4.05 years and 1.14 years (p=0.44 and p=0.10). Similarly, TS status did not predict the differential effects of (neo)adjuvant chemotherapy on OS (TS- p = 0.72, TS+ p = 0.49) or DFS (TS- p = 0.91, TS+ p = 0.28). Median OS for the TP+ group (n=10) was 4.35 years and DFS was 0.50 years, which were not significantly different from those of the TP- group (n=89): 4.05 years and 1.52 years (p=0.66 and p=0.24). TS/TP- tumors did not demonstrate improved OS (4.04 vs 4.51 years; p = 0.47) or DFS (1.20 years vs 1.96 years; p = 0.17). Similarly, TS/TP status did not predict the differential effects of (neo)adjuvant chemotherapy on OS (TS/TP- p = 0.73, TS/TP+ p = 0.67) or DFS (TS/TP- p = 0.95, TS/TP+ p = 0.40) Conclusions: TS and TP individually or in combination as measured using IHC appear not to be important prognostic indicators of OS or DFS in patients who underwent potentially curative liver resections for CLM. In addition these classifications can not be used to predict the differential effects of (neo)adjuvant chemotherapy in these patients. No significant financial relationships to disclose.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.070
GPT teacher head0.415
Teacher spread0.346 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2004
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicColorectal Cancer Treatments and StudiesFrench-language works237,207